AG
GILD icon

Ascent Group’s Gilead Sciences GILD Stock Holding History

Ascent Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8M Buy
63,356
+1,172
+2% +$154K 0.24% 95
2026
Q1 		$8.67M Sell
62,184
-703
-1% -$98.4K 0.3% 74
2025
Q4 		$7.72M Buy
62,887
+1,637
+3% +$199K 0.26% 79
2025
Q3 		$6.8M Buy
61,250
+11,926
+24% +$1.36M 0.24% 90
2025
Q2 		$5.47M Buy
49,324
+17,016
+53% +$1.81M 0.21% 98
2025
Q1 		$3.62M Buy
32,308
+11,200
+53% +$1.16M 0.16% 145
2024
Q4 		$1.95M Buy
21,108
+4,435
+27% +$399K 0.15% 175
2024
Q3 		$1.4M Buy
16,673
+3,813
+30% +$291K 0.11% 239
2024
Q2 		$882K Sell
12,860
-2,282
-15% -$152K 0.07% 284
2024
Q1 		$1.11M Sell
15,142
-1,421
-9% -$109K 0.1% 267
2023
Q4 		$1.23M Sell
16,563
-25,915
-61% -$2.02M 0.12% 224
2023
Q3 		$3.19M Buy
42,478
+2,555
+6% +$197K 0.35% 65
2023
Q2 		$3.2M Sell
39,923
-1,081
-3% -$86.2K 0.35% 71
2023
Q1 		$3.4M Sell
41,004
-7,133
-15% -$591K 0.36% 67
2022
Q4 		$4.13M Buy
48,137
+2,967
+7% +$235K 0.49% 46
2022
Q3 		$3.54M Buy
45,170
+18,907
+72% +$1.19M 0.43% 52
2022
Q2 		$1.57M Buy
26,263
+13,115
+100% +$812K 0.19% 164
2022
Q1 		$782K Buy
13,148
+6,527
+99% +$417K 0.09% 246
2021
Q4 		$454K Buy
+6,621
New +$456K 0.06% 309

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ascent Group's GILD Position: Q2 2026 in Review

Ascent Group increased its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, buying an estimated $154K and bringing the position to 63,356 shares worth $8M. The position accounts for 0.24% of the portfolio, ranked #95.

Ascent Group first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.67M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ascent Group held 63,356 shares of Gilead Sciences worth $8M as of Q2 2026.
  • Ascent Group bought 1,172 Gilead Sciences shares in Q2 2026, an estimated $154K.
  • Gilead Sciences made up 0.24% of Ascent Group's portfolio in Q2 2026, its #95 holding.
  • Ascent Group first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Ascent Group's Gilead Sciences position peaked at $8.67M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.